140 related articles for article (PubMed ID: 37423968)
21. Absorption, metabolism, distribution and excretion of (-)-epicatechin: A review of recent findings.
Borges G; Ottaviani JI; van der Hooft JJJ; Schroeter H; Crozier A
Mol Aspects Med; 2018 Jun; 61():18-30. PubMed ID: 29126853
[TBL] [Abstract][Full Text] [Related]
22. Influence of formulation and processing on absorption and metabolism of flavan-3-ols from tea and cocoa.
Neilson AP; Ferruzzi MG
Annu Rev Food Sci Technol; 2011; 2():125-51. PubMed ID: 22129378
[TBL] [Abstract][Full Text] [Related]
23. Flavan-3-ol Microbial Metabolites Modulate Proteolysis in Neuronal Cells Reducing Amyloid-beta (1-42) Levels.
Cecarini V; Cuccioloni M; Zheng Y; Bonfili L; Gong C; Angeletti M; Mena P; Del Rio D; Eleuteri AM
Mol Nutr Food Res; 2021 Sep; 65(18):e2100380. PubMed ID: 34318994
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the Interindividual Variability Associated with the Microbial Metabolism of (-)-Epicatechin.
Lessard-Lord J; Roussel C; Guay V; Desjardins Y
J Agric Food Chem; 2023 Sep; 71(37):13814-13827. PubMed ID: 37683128
[TBL] [Abstract][Full Text] [Related]
25. Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites.
Appeldoorn MM; Vincken JP; Aura AM; Hollman PC; Gruppen H
J Agric Food Chem; 2009 Feb; 57(3):1084-92. PubMed ID: 19191673
[TBL] [Abstract][Full Text] [Related]
26. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy.
Auger C; Mullen W; Hara Y; Crozier A
J Nutr; 2008 Aug; 138(8):1535S-1542S. PubMed ID: 18641203
[TBL] [Abstract][Full Text] [Related]
27. Metabotypes of flavan-3-ol colonic metabolites after cranberry intake: elucidation and statistical approaches.
Mena P; Favari C; Acharjee A; Chernbumroong S; Bresciani L; Curti C; Brighenti F; Heiss C; Rodriguez-Mateos A; Del Rio D
Eur J Nutr; 2022 Apr; 61(3):1299-1317. PubMed ID: 34750642
[TBL] [Abstract][Full Text] [Related]
28. Flavonoid-Derived Human Phenyl-γ-Valerolactone Metabolites Selectively Detoxify Amyloid-β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease.
Ruotolo R; Minato I; La Vitola P; Artioli L; Curti C; Franceschi V; Brindani N; Amidani D; Colombo L; Salmona M; Forloni G; Donofrio G; Balducci C; Del Rio D; Ottonello S
Mol Nutr Food Res; 2020 Mar; 64(5):e1900890. PubMed ID: 31914208
[TBL] [Abstract][Full Text] [Related]
29. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols.
Clifford MN; van der Hooft JJ; Crozier A
Am J Clin Nutr; 2013 Dec; 98(6 Suppl):1619S-1630S. PubMed ID: 24172307
[TBL] [Abstract][Full Text] [Related]
30. Impact of polyphenol oxidase on the bioavailability of flavan-3-ols in fruit smoothies: a controlled, single blinded, cross-over study.
Ottaviani JI; Ensunsa JL; Fong RY; Kimball J; Medici V; Kuhnle GGC; Crozier A; Schroeter H; Kwik-Uribe C
Food Funct; 2023 Sep; 14(18):8217-8228. PubMed ID: 37615673
[TBL] [Abstract][Full Text] [Related]
31. Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts.
Redan BW; Chegeni M; Ferruzzi MG
Food Funct; 2017 Jan; 8(1):111-121. PubMed ID: 27808339
[TBL] [Abstract][Full Text] [Related]
32. Human colonic catabolism of dietary flavan-3-ol bioactives.
Di Pede G; Mena P; Bresciani L; Almutairi TM; Del Rio D; Clifford MN; Crozier A
Mol Aspects Med; 2023 Feb; 89():101107. PubMed ID: 35931563
[TBL] [Abstract][Full Text] [Related]
33. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans.
Roowi S; Stalmach A; Mullen W; Lean ME; Edwards CA; Crozier A
J Agric Food Chem; 2010 Jan; 58(2):1296-304. PubMed ID: 20041649
[TBL] [Abstract][Full Text] [Related]
34. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.
She ZG; Chen HZ; Yan Y; Li H; Liu DP
Antioxid Redox Signal; 2012 Mar; 16(6):597-632. PubMed ID: 21867409
[TBL] [Abstract][Full Text] [Related]
35. Flavan-3-ol-enriched dark chocolate and white chocolate improve acute measures of platelet function in a gender-specific way--a randomized-controlled human intervention trial.
Ostertag LM; Kroon PA; Wood S; Horgan GW; Cienfuegos-Jovellanos E; Saha S; Duthie GG; de Roos B
Mol Nutr Food Res; 2013 Feb; 57(2):191-202. PubMed ID: 23136121
[TBL] [Abstract][Full Text] [Related]
36. Dietary intakes of flavan-3-ols and cardiovascular health: a field synopsis using evidence mapping of randomized trials and prospective cohort studies.
Raman G; Shams-White M; Avendano EE; Chen F; Novotny JA; Cassidy A
Syst Rev; 2018 Jul; 7(1):100. PubMed ID: 30021626
[TBL] [Abstract][Full Text] [Related]
37. Assessing the Gut Microbiota's Ability to Metabolize Oligomeric and Polymeric Flavan-3-ols from Aronia and Cranberry.
Lessard-Lord J; Roussel C; Guay V; Desjardins Y
Mol Nutr Food Res; 2024 Mar; 68(5):e2300641. PubMed ID: 38350729
[TBL] [Abstract][Full Text] [Related]
38. Review: The role of paraoxonase in cardiovascular diseases.
Kowalska K; Socha E; Milnerowicz H
Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
[TBL] [Abstract][Full Text] [Related]
39. Characterization of new flavan-3-ol derivatives in fermented cocoa beans.
Fayeulle N; Vallverdu-Queralt A; Meudec E; Hue C; Boulanger R; Cheynier V; Sommerer N
Food Chem; 2018 Sep; 259():207-212. PubMed ID: 29680045
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic Effects of Flavan-3-ols and Their Microbial Metabolites.
Márquez Campos E; Jakobs L; Simon MC
Nutrients; 2020 May; 12(6):. PubMed ID: 32485837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]